|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 183.93 AUD | +2.86% |
|
-0.09% | -34.68% |
| 12-09 | Shares of CSL Fall After Audit Office Statement on Unit's Vaccine Deal | MT |
| 12-08 | CSL's China Albumin Sale to Improve in Fiscal H2 2026, Says Jefferies | MT |
| Capitalization | 58.96B 50.23B 46.92B 44.15B 81.28B 5,341B 88.79B 548B 212B 2,517B 221B 217B 9,185B | P/E ratio 2026 * |
23.3x | P/E ratio 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise value | 67.72B 57.69B 53.89B 50.71B 93.35B 6,134B 102B 629B 244B 2,891B 254B 249B 10,549B | EV / Sales 2026 * |
4.23x | EV / Sales 2027 * | 3.99x |
| Free-Float |
99.9% | Yield 2026 * |
2.53% | Yield 2027 * | 2.75% |
Last Transcript: CSL Limited
| 1 day | +2.86% | ||
| 1 week | -0.09% | ||
| Current month | -1.27% | ||
| 1 month | +2.72% | ||
| 3 months | -11.50% | ||
| 6 months | -23.70% | ||
| Current year | -34.68% |
| 1 week | 178.12 |  | 186.5 |
| 1 month | 175.77 | | 188.67 |
| Current year | 168 | | 290.32 |
| 1 year | 168 | | 290.32 |
| 3 years | 168 | | 314.28 |
| 5 years | 168 | | 319.78 |
| 10 years | 91.62 | | 342.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul McKenzie
CEO | Chief Executive Officer | 59 | 05/03/2023 |
Ken Lim
DFI | Director of Finance/CFO | 51 | 06/10/2025 |
Mark Hill
CTO | Chief Tech/Sci/R&D Officer | 63 | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 71 | 16/10/2018 | |
Marie McDonald
BRD | Director/Board Member | 69 | 13/08/2013 |
Megan Clark
BRD | Director/Board Member | 67 | 15/02/2016 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.91% | 26 M€ | +12.27% | - |
| 2.49% | 8 M€ | +23.59% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.86% | -0.09% | -33.92% | -38.32% | 58.96B | |
| -0.74% | +3.19% | +0.04% | -0.16% | 76.06B | |
| -2.24% | -4.93% | +29.50% | +225.99% | 52.48B | |
| +1.38% | +69.20% | +69.20% | +69.20% | 53.01B | |
| +0.93% | -3.97% | +12.08% | -40.09% | 25.54B | |
| -0.72% | -6.94% | +34.70% | +15.85% | 18.73B | |
| +1.85% | -7.39% | +123.62% | +166.25% | 18.76B | |
| -4.52% | -5.15% | +38.56% | +1,015.98% | 15.67B | |
| +1.46% | +2.05% | +171.59% | +723.11% | 14.48B | |
| -0.04% | -.--% | +58.12% | +150.28% | 14.02B | |
| Average | +0.02% | -1.97% | +50.35% | +228.81% | 34.77B | |
| Weighted average by Cap. | +0.18% | -0.70% | +29.91% | +126.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16B 13.63B 12.73B 11.98B 22.06B 1,449B 24.1B 149B 57.65B 683B 60.04B 58.78B 2,493B | 16.74B 14.26B 13.32B 12.54B 23.08B 1,517B 25.21B 156B 60.33B 715B 62.83B 61.5B 2,608B |
| Net income | 2.58B 2.2B 2.05B 1.93B 3.55B 234B 3.88B 23.95B 9.29B 110B 9.68B 9.47B 402B | 3.43B 2.92B 2.73B 2.57B 4.73B 311B 5.17B 31.87B 12.36B 147B 12.88B 12.6B 534B |
| Net Debt | 8.76B 7.46B 6.97B 6.56B 12.08B 793B 13.19B 81.37B 31.56B 374B 32.87B 32.18B 1,365B | 7.85B 6.69B 6.25B 5.88B 10.82B 711B 11.82B 72.9B 28.28B 335B 29.45B 28.83B 1,222B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/12/25 | 183.93 $ | +2.86% | 973,901 |
| 11/12/25 | 178.81 $ | -1.55% | 855,310 |
| 10/12/25 | 181.63 $ | -0.10% | 693,730 |
| 09/12/25 | 181.82 $ | -1.98% | 878,270 |
| 08/12/25 | 185.50 $ | +0.76% | 600,386 |
Delayed Quote Australian S.E., December 12, 2025 at 05:12 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CSL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition